Independent report

Vivaldi 3: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes

Report setting out the results of a study of 124 staff and residents in 19 long term care homes who have received an mRNA booster following 2 doses of either Pfizer or AstraZeneca between May and November 2021

• From: UK Health Security Agency
• Published: 23 December 2021

Documents

Vivaldi 3: Booster vaccination strongly enhances SARS-CoV-2-specific antibody and cellular responses in elderly residents of care homes

HTML

Details

The Vivaldi 3 study, conducted by the University of Birmingham in collaboration with University College London, is an integral part of the Vivaldi project which was set up in June 2020 to investigate SARS-CoV-2 transmission, infection outcomes and immunity in residents and staff in care homes in England.

Published 23 December 2021